Effect of propranolol in retinopathy
Phase 3
- Conditions
- Retinopathy of prematurity.Retinopathy of prematurity
- Registration Number
- IRCT20100520003982N1
- Lead Sponsor
- Yazd University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Preterm infants less than 1500 gr
Preterm infants with gestational age greater than 26 weeks and less than 32 weeks
Preterm infants with retinopathy grade I and II ROP
Preterm infants admitted to NICU.
Exclusion Criteria
Congenital malformation
cardiovascular problems except Patent Ductus Arteriosus (PAD)
active sepsis
Congenital infections (TORCH)
Intraventricular hemorrhage (IVH) Grade II and III
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Retinopathy process. Timepoint: On the 28th day after birth (before entering the study), every week until the end of study. Method of measurement: Indirect ophthalmoscopy.
- Secondary Outcome Measures
Name Time Method